InMed Pharmaceuticals (INM) Free Cash Flow Growth (3y) (2022 - 2026)
Powered by 
Analysis
InMed Pharmaceuticals (INM) Free Cash Flow Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.55 Bn | 143.04 Bn | 1.63 Bn | 77.64% |
| 2 | Ati | 28.35 Bn | 27.57 Bn | 309.80 Mn | - |
| 3 | Qnity Electronics | 26.32 Bn | 25.36 Bn | 666.00 Mn | - |
| 4 | International Flavors & Fragrances | 21.50 Bn | 20.93 Bn | 853.00 Mn | 29.07% |
| 5 | DuPont de Nemours | 17.42 Bn | 15.68 Bn | 639.00 Mn | 5.36% |
| 6 | Avery Dennison | 12.98 Bn | 12.75 Bn | 729.40 Mn | 38.73% |
| 7 | Solstice Advanced Materials | 10.02 Bn | 9.27 Bn | 370.00 Mn | - |
| 8 | Element Solutions | 8.75 Bn | 8.56 Bn | 334.00 Mn | 2.23% |
| 9 | Eastman Chemical | 7.83 Bn | 7.14 Bn | 560.00 Mn | -10.16% |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - | 1.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.80% |
| Dec 31, 2025 | 4.32% |
| Sep 30, 2025 | 10.60% |
| Jun 30, 2025 | 24.11% |
| Mar 31, 2025 | 32.32% |
| Dec 31, 2024 | 8.99% |
| Sep 30, 2024 | 14.32% |
| Jun 30, 2024 | 19.95% |
| Mar 31, 2024 | 25.14% |
| Dec 31, 2023 | -1.08% |
| Sep 30, 2023 | -16.15% |
| Jun 30, 2023 | 20.98% |
| Mar 31, 2023 | -5.38% |
| Dec 31, 2022 | -9.05% |
| Sep 30, 2022 | 2.09% |